Testosterone Propionate (Cattle Implant Component)
Testosterone propionate is the androgenic component of steer-specific cattle growth implants such as Synovex-S and Revalor-S, usually paired with estradiol benzoate. In the implant it drives weight gain in feedlot steers; the same short-ester testosterone is also the classic diverted androgen for human PED use.
01 Overview
In combination cattle implants, testosterone propionate supplies the androgenic half of an androgen-plus-estrogen blend that boosts weight gain and feed efficiency in steers. The propionate ester is short-acting, chosen to match the implant's release profile.
The identical molecule is the original injectable testosterone ester used in human medicine and, illicitly, in bodybuilding, where its short ester gives fast onset and quick clearance. This entry addresses the veterinary implant component and its role as a growth-promotant androgen; diverted human use carries the full testosterone side-effect profile plus veterinary-sourcing risks.
02 Mechanism
Testosterone is the prototypical androgen-receptor agonist; it aromatises to estradiol and is 5-alpha reduced to DHT. The propionate ester gives short-duration release from oil or implant matrix.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Diverted human use (anecdotal) | 300–500 mg/wk | IM | Illicit human dosing of the ester; veterinary use is as a cattle implant |
Ester comparison
| Ester | Half-life | Injection freq. | Testosterone by mass |
|---|
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| Increased weight gain (steers)As an implant component it raises average daily gain and feed efficiency, synergising with estradiol. | +8-15% ADG | Clinical | |
| Lean mass and strength (if diverted)The testosterone molecule produces robust lean-mass and strength gains in humans. | Clinical |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Estrogenic effectsAromatisation can cause gynecomastia and water retention. | Moderate | Dose-dependent | Clinical | |
| HPTA suppressionSuppresses endogenous testosterone production during exogenous administration. | Severe | Universal at PED doses | Clinical |